Hereditary Cancer

The mapping of the human genome has provided medical professionals with the ability to refine a patient’s cancer risk through the analysis of inherited mutations.

Luminus’ genetic tests screen a number of known genes related to hereditary cancers. The goal of every test is to determine a patient’s risk of cancer. This knowledge can help your physician to develop the appropriate or preventative treatment plan for early detection. If the results of your test indicate an increased risk for cancer, your doctor may order tests like mammograms, colonoscopy and CT scans for any possible diagnosis and immediate intervention.

Breast Cancer Panel BRCA1 and BRCA2

Having mutations in either the BRCA1 or the BRCA2 gene significantly increases a patient’s risk for breast, ovarian and other types of cancer.

High Risk Breast Cancer Panel

(Ashkenazi Jewish, Hispanic with Reflexive options)

High Risk Panel is a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2. Three independent testing platforms include 3 site Ashkenazi Jewish panel and 8 site Hispanic testing panel.

Recent studies of breast cancer survivors have shown that approximately 70 percent of the mutations identified were BRCA1/2 mutations. Approximately 4 percent had germline mutations in other cancer-susceptibility genes, including high-risk genes. These additional high-risk genes include CDH1, PALB2, PTEN, STK11, and TP53. Luminus Diagnostics Breast High Risk Panel analyzes all of these genes.

Colorectal Cancer Panel

According to the Centers for Disease Control and Prevention (CDC) and the American Cancer Society, colorectal cancer is the second leading cause of cancer-related death in the United States, and the third most commonly diagnosed cancer in men and women. Overall, 1 in 20 individuals will develop colorectal cancer at some point during their life – equating to a 5% lifetime risk of developing colorectal cancer. Although the majority of colorectal cancer is sporadic, and caused by a variety of genetic and non-genetic factors, research has shown that approximately 5% of colorectal cancers are due to hereditary changes in single genes.

Lynch Syndrome


Luminus Lynch Syndrome genetic testing is a hereditary cancer panel designed for individuals suspected to be at-risk for Lynch (hereditary non-polyposis colon cancer or HNPCC) syndrome. Testing includes full sequencing of MLH1, MSH2, MSH6, and PMS2. Testing also includes deletion/duplication analysis for these four genes as well as the EPCAMgene.

alt tag



CALL US TODAY AT (888) 886-1167

  support@standardmed.us

  
We are a residential service agency and we provide skilled-nursing home service care, durable medical equipment, oxygen services and physical therapy.

Most health insurance and financing plans are accepted.

Hours

Monday9:00AM - 5:00PM
Tuesday9:00AM - 5:00PM
Wednesday9:00AM - 5:00PM
Thursday9:00AM - 5:00PM
Friday9:00AM - 5:00PM
SaturdayCLOSED
SundayCLOSED

If You Are Looking For A Healthcare Provider,

PLEASE CONTACT OUR SALES TEAM!
NEW YORK OFFICE

477 Madison Avenue,

6th floor,

New York, NY 10022

Email. support@standardmed.us

FLORIDA OFFICE

10752 Deerwood Park Blvd.,

Suite 100,

Jacksonville, FL 32256

Email. support@standardmed.us

MARYLAND OFFICE

8115 Maple Lawn Blvd.,

Suite #350 3rd Floor,

Fulton, MD 20759

Email. support@standardmed.us

Standard Medical Equipment Systems, LLC – DBA, (“Standard Med” ) is a certified minority (MBE) Veteran (SDVOSB) owned company, certified by the Center for Veteran Enterprises, (CVE).— Standard Med was established by Anthony B. Goodesmith, in the year 2005, to deliver high quality medical devices and laboratory equipment. Mr. Goodesmith served as a highly decorated combat signaler/communications officer in the U.S. Army and New Jersey National Guard for over 18 years. His units took part in Operation Desert Storm, and several other military campaigns after the 9/11 U.S. Terror Attacks (Operations Enduring Freedom and Noble Eagle). He received his B.S. in Marketing and Media Arts from Long Island University, NY, and his Master’s degree in Biotechnology Management from The University of Maryland University College (UMUC).Mr. Goodesmith has been working in the health care, medical industry in sales and management for over 20 years at several Fortune 500 pharmaceutical and medical device companies. Such as Eli Lilly & Company, Solvay Pharmaceuticals, AstraZeneca, Inc., Roche Laboratories, Inc. and now Standard Medical Systems, LLC. He has received the Elite Salesman Award, President’s Award, U.S. Congressional VIP Citation, and achieved #1 status in selling various pharmaceutical drugs and medical devices throughout his career. Mr. Goodesmith shares his tremendous expertise as a staff writer for the DC Health-Technology Examiner, based on his exceptional knowledge about the epidemiology of health-related issues and via medical device, regenerative, biological solutions. You may reach Mr. Goodesmith at his corporate email address: tony@standardmed.us. We pride ourselves on our distinct array of medical devices and diagnostic equipment we offer to the healthcare community, which delivers the highest quality control, safety and efficacy with the latest breakthroughs in medical technology.

Our ultimate aim is to work daily with the sole purpose of raising the standards of healthcare delivery for all people.
We are part of the health care technology industry. Our target market is the US Federal Government, VAMC’s, DOD, State and local municipal agencies, and the overall wholesale/retail healthcare consumer market. Our primary products are diagnostic medical devices, to include durable medical equipment, regenerative medicine, and surgical implants/ wound care products. Important characteristics of these products are to aid in the diagnosis and to facilitate treatment of particular disease states and physical ailments of various types. Our products differ from our competitors, in that we offer state of the art cutting edge medical devices, diagnostics and supplies in an underserved and specialized market population.

NEW YORK OFFICE

477 Madison Avenue,

6th floor,

New York, NY 10022

Email. support@standardmed.us

MARYLAND OFFICE

8115 Maple Lawn Blvd.,

Suite #350 3rd Floor,

Fulton, MD 20759

Email. support@standardmed.us

FLORIDA OFFICE

10752 Deerwood Park Blvd.,

Suite 100,

Jacksonville, FL 32256

Email. support@standardmed.us

Standard Medical Equipment Systems, LLC, Hospital Supplies, Fulton, MD